share_log

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥855m Last Week

Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Largest Shareholders Are Private Companies Who Were Rewarded as Market Cap Surged CN¥855m Last Week

上海好遠化學家實驗有限公司(SHSE:688131)的最大股東是私人公司,上週市值飆升了8550萬元。
Simply Wall St ·  08/30 20:27

Key Insights

主要見解

  • The considerable ownership by private companies in Shanghai Haoyuan Chemexpress indicates that they collectively have a greater say in management and business strategy
  • The top 6 shareholders own 52% of the company
  • 24% of Shanghai Haoyuan Chemexpress is held by Institutions
  • 上海昊源化學快遞私營公司的大量持有意味着它們在公司管理和業務策略方面擁有更大的發言權
  • 前6大股東擁有公司的52%股份。
  • 上海豪源化工(SHSE: 688131)24%的股權由機構持有。

Every investor in Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131) should be aware of the most powerful shareholder groups. We can see that private companies own the lion's share in the company with 40% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

上海豪源化工有限公司的每一位投資者都應該注意最強大的股東群體。我們可以看到,私人公司擁有公司40%的所有權。換句話說,該群體將在對該公司的投資中獲得最多的利益(或者承擔最大的風險)。

Clearly, private companies benefitted the most after the company's market cap rose by CN¥855m last week.

上週,公司市值增加了CN¥85500萬,私人公司受益顯而易見。

Let's delve deeper into each type of owner of Shanghai Haoyuan Chemexpress, beginning with the chart below.

讓我們深入探討上海浩源生物科技股份有限公司的每種所有者類型,從下面的圖表開始。

1725064032453
SHSE:688131 Ownership Breakdown August 31st 2024
SHSE:688131 所有權拆分報告 2024年8月31日

What Does The Institutional Ownership Tell Us About Shanghai Haoyuan Chemexpress?

機構持股告訴我們關於上海昊源化學快遞怎麼樣?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。

We can see that Shanghai Haoyuan Chemexpress does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Shanghai Haoyuan Chemexpress' historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到上海浩源生物科技股份有限公司確實有機構投資者,並且他們持有該公司的大部分股票。這可能意味着該公司在投資界具有一定的信譽度。然而,最好小心依賴機構投資者所帶來的所謂驗證。他們也會犯錯誤。當多個機構擁有一隻股票時,存在着它們參與一種「擁擠交易」的風險。當這樣的交易出錯時,多個方當中會有競相快速出售股票的情況。在一個沒有增長曆史的公司裏,這種風險更高。您可以在下方查看上海浩源生物科技股份有限公司的歷史收益和營業收入,但請記住故事總是更加複雜的。

1725064033916
SHSE:688131 Earnings and Revenue Growth August 31st 2024
SHSE:688131於2024年8月31日的盈利和營業收入增長

We note that hedge funds don't have a meaningful investment in Shanghai Haoyuan Chemexpress. Shanghai Anxu Information Technology Co., Ltd. is currently the largest shareholder, with 32% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.1% and 4.0% of the stock.

我們注意到,對上海浩源科技表現出戲劇性投資觀點的對沖基金不具有實質性投資。上海安迅信息科技有限公司目前是最大的股東,持有32%的股份。相比之下,第二大和第三大股東持有約7.1%和4.0%的股份。

On further inspection, we found that more than half the company's shares are owned by the top 6 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

雖然研究公司的機構所有權數據是有意義的,但研究分析師的情緒也是有意義的,以知道風向如何。就我們所知,目前並沒有該公司的分析師覆蓋。因此,可能被忽略了。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

研究機構所有權是衡量和過濾股票預期表現的好方法。通過研究分析師的情緒也可以實現同樣的目的。由於有相當數量的分析師涵蓋這支股票,因此了解他們對未來的整體看法可能會有所幫助。

Insider Ownership Of Shanghai Haoyuan Chemexpress

上海昊源化學快遞的內部股權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。

Our most recent data indicates that insiders own less than 1% of Shanghai Haoyuan Chemexpress Co., Ltd.. However, it's possible that insiders might have an indirect interest through a more complex structure. It seems the board members have no more than CN¥9.7m worth of shares in the CN¥4.8b company. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling.

我們最近的數據顯示,內部持股不到上海浩遠化學實驗有限公司的1%。然而,內部人可能通過更復雜的結構間接持有利益。董事會成員在這個價值爲48億人民幣的公司中持有不到970萬人民幣的股份。許多投資者更希望在較小的公司中看到董事會更加重視投資。您可以點擊這裏查看這些內部人是否一直在購買或出售。

General Public Ownership

一般大衆所有權

The general public, who are usually individual investors, hold a 27% stake in Shanghai Haoyuan Chemexpress. This size of ownership, while considerable, may not be enough to change company policy if the decision is not in sync with other large shareholders.

一般公衆,通常是個人投資者,在上海浩遠化學實驗中持有27%的股份。儘管這種持股規模相當大,但如果決定與其他大股東不一致,可能不足以改變公司政策。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

Private equity firms hold a 7.1% stake in Shanghai Haoyuan Chemexpress. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

私募股權公司持有上海昊源化學快遞7.1%的股權。這表明他們在關鍵政策決策中可能具有影響力。一些投資者可能會因此得到鼓勵,因爲私募股權公司有時能夠鼓勵市場看到公司的價值。或者像在上市後那樣,這些持有者可能正在退出投資。

Private Company Ownership

私有公司的所有權

Our data indicates that Private Companies hold 40%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據表明,私人公司持有該公司40%的股份。 私人公司可能是相關方。 有時,內部人員會通過持有私人公司的股份來對公共公司產生影響,而不是作爲個人容量。 雖然很難得出廣泛的結論,但值得注意作爲進一步研究的領域。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand Shanghai Haoyuan Chemexpress better, we need to consider many other factors. Case in point: We've spotted 3 warning signs for Shanghai Haoyuan Chemexpress you should be aware of.

在考慮所有股東時,始終值得考慮不同的群體。但想要更好地了解上海好遠化學實驗,我們需要考慮許多其他因素。事實上:我們已經注意到上海好遠化學實驗有3個警告信號,你應該注意到。

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

但最終,決定該業務所有者將獲得多大利益的是未來而非過去。因此,我們認爲最好查看此免費報告,以了解分析師是否預測更光明的未來。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論